Marketing-authorisation holder · Spain
Vifor Fresenius Medical Care Renal Pharma France
8 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
8 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| KAPRUVIA 50 MICROGRAMOS/ML SOLUCION INYECTABLE55 microgramos/ml · Solución inyectable | Difelikefalin | Spain | Authorised | 2022 |
| RAYALDEE 30 MICROGRAMOS CAPSULAS BLANDAS DE LIBERACION PROLONGADA0,03 mg · Cápsula blanda de liberación prolongada | Calcifediol | Spain | Authorised | 2020 |
| Velphoro 500 mg comprimidos masticables500 mg · Comprimido masticable | Sucroferric oxyhydroxide | Spain | Authorised | 2014 |
| Velphoro 500 mg comprimidos masticables500 mg · Comprimido masticable | Sucroferric oxyhydroxide | Spain | Marketed | 2014 |
| VELTASSA 1 G POLVO PARA SUSPENSION ORAL2 g · Polvo para suspensión oral | Patiromer calcium | Spain | Authorised | 2025 |
| VELTASSA 16,8 G POLVO PARA SUSPENSION ORAL33.60 g · Polvo para suspensión oral | Patiromer calcium | Spain | Marketed | 2018 |
| VELTASSA 8,4 G POLVO PARA SUSPENSION ORAL16.80 g · Polvo para suspensión oral | Patiromer calcium | Spain | Marketed | 2018 |
| TAVNEOS 10 MG CAPSULAS DURAS10 mg · Cápsula dura | Avacopan | Spain | Withdrawn | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 7 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.